Search results for "Liver"

showing 10 items of 4961 documents

Proposal for an Alliance Between Healthcare and Legal Area Professionals for Shared Public Health and Preventive Strategies in Italy and Europe

2020

Following the implementation of the new Italian legislation on responsibility of healthcare workers, a multi-professional framework, involving representatives of the Italian public health professionals and legal professionals expert in the field, drafted a proposal of the actionable recommendations to be implemented in the management of civil and penal disputes arising from the practice of public health interventions. In order to prevent legal disputes concerning some public health fields such as vaccinations, cancer screening, environmental health surveillance, and hospital management, it should be primary taken into account to update guidelines in supporting decision-making processes, in …

medicine.medical_specialtyLegislationSettore MED/42 - Igiene Generale E ApplicataScientific evidence03 medical and health sciencesmandatory vaccination0302 clinical medicineOrder (exchange)Multidisciplinary approachPolitical scienceHealth caremedicineHumans030212 general & internal medicinehospital managementLegal professionhealth care economics and organizationsbusiness.industry030503 health policy & servicesPublic healthlcsh:Public aspects of medicinemultidisciplinary approach healthcare disputes mandatory vaccination cancer screening environmental health surveillance hospital managementPublic Health Environmental and Occupational HealthCancer screening; Environmental health surveillance; Healthcare disputes; Hospital management; Mandatory vaccination; Multidisciplinary approachlcsh:RA1-1270Public relationshumanitiesPolicy BriefEuropeAllianceItalycancer screeninghealthcare disputesmultidisciplinary approachPublic HealthHealth Facilities0305 other medical sciencebusinessenvironmental health surveillanceDelivery of Health CareFrontiers in Public Health
researchProduct

Pharmacokinetics of anidulafungin during albumin dialysis

2014

In the ICU setting, current guidelines recommend echi-nocandins as the first-line treatment for invasive candi-diasis [1]. Albumin dialysis (AD) has been used in theICU as supportive therapy for hepatic failure, but thistechnique can significantly enhance drug elimination [2].We prescribed anidulafungin for suspected invasivecandidiasis in a patient with severe liver failure treatedwith AD and measured the plasma concentrations of thedrug using high-performance liquid chromatography.This study (GEF-ANI-2010-02) was approved by thelocal ethics committee (INCLIVA, Institute of Research,Valencia, Spain) and written informed consent wasobtained from the patient’s next of kin. An adult patientwa…

medicine.medical_specialtyLetterbusiness.industrymedicine.medical_treatmentAlbuminUrineCritical Care and Intensive Care MedicineLoading doseSurgeryPharmacokineticsAnesthesiamedicineAnidulafunginLiver functionHepatectomybusinessDialysismedicine.drugCritical Care
researchProduct

Non-alcoholic fatty liver disease pathogenesis: The present and the future

2008

Non-alcoholic fatty liver disease is the clinical hepatic expression of metabolic syndrome. The prevalence of non-alcoholic fatty liver disease is around 20-30%, and with a rapid increase in the metabolic risk factors in the general population, non-alcoholic fatty liver disease has become the most common cause of liver disease worldwide. A fraction (20-30%) of non-alcoholic fatty liver disease patients develop a potentially progressive hepatic disorder, namely non-alcoholic steatohepatitis, leading to end-stage liver disease. The pathogenesis of non-alcoholic fatty liver disease is not entirely understood, and even if insulin resistance is a major pathogenetic key, many other factors are im…

medicine.medical_specialtyLipolysisPopulationPhysiologyApoptosisMitochondria LiverInsulin resistance Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis SteatosisDiseaseFatty Acids NonesterifiedPathogenesisLiver diseaseInsulin resistanceAdipokinesRisk FactorsInternal medicinemedicineAnimalsHumansGenetic Predisposition to Diseaseeducationeducation.field_of_studyHepatologybusiness.industryFatty liverGastroenterologymedicine.diseaseDietFatty LiverOxidative StressEndocrinologyAdipose TissueLiverDisease ProgressionHepatocytesCytokinesInsulin ResistanceSteatohepatitisMetabolic syndromebusinessDigestive and Liver Disease
researchProduct

Elevated Expression of Liver γ-Cystathionase Is Required for the Maintenance of Lactation in Rats

1999

Liver gamma-cystathionase activity increases in rats during lactation; its inhibition due to propargylglycine is followed by a significant decrease in lactation. This is reversible by N-acetylcysteine administration. To study the role of liver gamma-cystathionase and the intertissue flux of glutathione during lactation, we used lactating and virgin rats fed liquid diets. Virgin rats were divided into two groups as follows: one group was fed daily a diet containing the same amount of protein that was consumed the previous day by lactating rats (high protein diet-fed rats); the other virgin group was fed the normal liquid diet (control). The expression and activity of liver gamma-cystathionas…

medicine.medical_specialtyLiquid dietMammary glandGlycineMedicine (miscellaneous)Biologychemistry.chemical_compoundMammary Glands AnimalInternal medicineLactationmedicineAnimalsLactationCysteineAmino AcidsEnzyme InhibitorsRats WistarLiver sizechemistry.chemical_classificationNutrition and DieteticsCystathionine gamma-lyaseCystathionine gamma-LyaseGlutathioneGlutathioneAcetylcysteineRatsMilkEnzymeEndocrinologymedicine.anatomical_structureLiverchemistryAlkynesCystineFemaleDietary ProteinsOxidation-ReductionCysteineThe Journal of Nutrition
researchProduct

Evidence-based medicine and the problem of healthy volunteers

2017

Abstract Healthy controls are subjects without the disease being studied but may have other conditions indirectly affecting outcome. In the present epidemics of obesity a few subjects with undiagnosed nonalcoholic fatty liver disease enter clinical studies as controls, producing biased results. Stricter selection criteria should be considered to prevent this risk.

medicine.medical_specialtyLiver EnzymesSpecialties of internal medicinePredictive Value of TestDiseaseGastroenterology03 medical and health sciences0302 clinical medicineClinical trialsLiver Function TestsPredictive Value of TestsReference ValuesNon-alcoholic Fatty Liver DiseaseLiver enzymeInternal medicineNAFLDHealthy volunteersNonalcoholic fatty liver diseasemedicineHumansReference ValueObesitySelection (genetic algorithm)Evidence-Based MedicineHepatologybusiness.industryLiver Function TestPatient SelectionLiver enzymeControl groupGeneral MedicineEvidence-based medicineClinical trials. Control group. Liver Enzymes. NAFLD. Obesitymedicine.diseaseObesityHealthy VolunteerHealthy VolunteersClinical trialClinical trialRC581-951030211 gastroenterology & hepatologybusiness030217 neurology & neurosurgeryHuman
researchProduct

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative…

2010

Background Oral deferiprone was suggested to be more effective than subcutaneous desferrioxamine for removing heart iron. Oral once-daily chelator deferasirox has recently been made commercially available but its long-term efficacy on cardiac iron and function has not yet been established. Our study aimed to compare the effectiveness of deferasirox, deferiprone and desferrioxamine on myocardial and liver iron concentrations and bi-ventricular function in thalassemia major patients by means of quantitative magnetic resonance imaging. Design and Methods From the first 550 thalassemia subjects enrolled in the Myocardial Iron Overload in Thalassemia network, we retrospectively selected thalasse…

medicine.medical_specialtyLiver Iron ConcentrationthalassemiaThalassemiairon chelation therapycardiac magnetic resonance imagingGastroenterologythalassemia; iron chelation therapy; cardiac magnetic resonance imagingNOchemistry.chemical_compoundCardiac magnetic resonance imagingInternal medicinemedicinemedicine.diagnostic_testbusiness.industryDeferasiroxBeta thalassemiaMagnetic resonance imagingHematologymedicine.diseaseSurgeryDeferoxaminechemistrybusinessDeferipronemedicine.drug
researchProduct

The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells

1997

Oval cells are small nonparenchymal epithelial cells that first appear in the periportal areas of the liver and thereafter invade the whole parenchyma when mice or rats are exposed to a variety of chemical carcinogens. In the present study we have analyzed the expression of insulin-like growth factor II (IGF II) in the recently established oval cell line OC/CDE 22 and its malignantly transformed counterpart (the M22 cells) and the biological consequences of the constitutive expression of IGF II in oval cells. OC/CDE 22 cells do not express the above-mentioned growth factor, whereas the M22 cells do and addition of a neutralizing anti-IGF II antibody to M22 cells resulted in an almost comple…

medicine.medical_specialtyLiver cytologymedicine.medical_treatmentBiologyCell LineMalignant transformationMiceLiver Neoplasms ExperimentalGrowth factor receptorInsulin-Like Growth Factor IINeutralization TestsInternal medicinemedicineAnimalsAutocrine signallingHepatologyGrowth factorEpithelial CellsOncogenesTransfectionMolecular biologyRatsCell Transformation NeoplasticEndocrinologyLiverCell cultureInsulin-like growth factor 2biology.proteinMitogensHepatology
researchProduct

Forecasting liver disease burden

2018

medicine.medical_specialtyLiver diseaseHepatologybusiness.industryGastroenterologymedicineIntensive care medicinemedicine.diseasebusinessDigestive and Liver Disease
researchProduct

Surgery in patients with liver disease

1999

medicine.medical_specialtyLiver diseaseHepatologybusiness.industrymedicineIn patientmedicine.diseasebusinessSurgeryHepatology
researchProduct

Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?

2019

Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in ultrasonography (US), and it is being increasingly used for the evaluation of focal liver lesions (FLLs). CEUS is unique in that it allows non-invasively assessment of liver perfusion in real time throughout the vascular phase, which has led to dramatic improvements in the diagnostic accuracy of US in the detection and characterization of FLLs, the choice of therapeutic procedures, and the evaluation of response. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, including in cirrhotic patients with hepatocellular carcinoma, resulting in better patient management and cost-effective d…

medicine.medical_specialtyLiver perfusionlcsh:Medical technologyHepatocellular carcinomaDiagnostic accuracyReview Article030218 nuclear medicine & medical imagingUltrasound contrast mediaLiver cirrhosi03 medical and health sciences0302 clinical medicinemedicineContrast-enhanced ultrasonographyRadiology Nuclear Medicine and imagingUltrasound contrast mediaUltrasonographybusiness.industryUltrasoundmedicine.diseasePatient managementlcsh:R855-855.5LiverHepatocellular carcinomaLiver cirrhosis030211 gastroenterology & hepatologyRadiologyUltrasonographybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaContrast-enhanced ultrasoundUltrasonography
researchProduct